Rebus Holdings, Inc., together with its subsidiaries, focuses on the research and development of precision therapeutics for the treatment of cancer. Its lead asset is RT-AR001, an adenosine receptor antagonist for tumor infiltration and enhanced outcomes when administered intra-tumorally. Rebus Holdings, Inc. was incorporated in 2003 and is based in Westlake Village, California.
Frequently asked questions
What sector does Rebus Holdings Inc. (RBSH) operate in?
Rebus Holdings Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Rebus Holdings Inc. (RBSH) current stock price?
As of the latest data, Rebus Holdings Inc. stock price is $0.00, with a previous close of $0.00.
What is Rebus Holdings Inc. (RBSH) current market capitalization?
Rebus Holdings Inc. market cap is approximately 3.21 thousand.
Does Rebus Holdings Inc. (RBSH) pay dividends?
No. Rebus Holdings Inc. does not pay a dividend.
What is Rebus Holdings Inc. (RBSH) beta (volatility) score?
Rebus Holdings Inc. has a beta of -41.160, indicating lower volatility than the overall market.